Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 4 hours ago
AACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugs
about 4 hours ago
Just a few years ago, Daniel Chen, M.D., Ph.D., was spending his...
FDA celebrates progress to end animal testing but experts warn there’s still a long way to go
about 4 hours ago
The FDA says it has hit the one-year goals of its roadmap...
AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
1 day ago
Asked by Fierce if he'd consider returning to the FDA, Pazdur said...
Biomarkers are reshaping oncology trial design
2 days ago
Discover how biomarker strategies are transforming oncology trials and accelerating precision medicine...
Merck unveils PD-1xVEGF bispecific data in NSCLC, remains tight-lipped on phase 3 plans
2 days ago
More than a year after licensing its PD-1xVEGF bispecific, Merck & Co...
UCB pays $650M+ for Neurona, marking 'strategic expansion' into regenerative medicine
2 days ago
The agreement fulfills several ambitions for UCB. Besides building its epilepsy position...
When Spray Drying Falls Short: A Faster Path Forward
2 days ago
Learn how early intervention can help drug developers convert suboptimal formulations into...
3 bioprocessing trends—and the critical enabler that’s quietly driving them
2 days ago
Bioprocessing is evolving rapidly in a shifting landscape of innovative and complex...
Chutes & Ladders—Metsera acquisition architect swings to Structure
3 days ago
After helping guide Metsera through its high-profile, $10 billion acquisition by Pfizer...
OpenAI launches biotech-specific AI model dubbed GPT-Rosalind
3 days ago
Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a...
Abbott lowers EPS guidance on Exact Sciences buy as shares slide
3 days ago
Abbott is dealing with integrating a big new buyout into its business...
Roivant’s CEO thinks China is a ‘red herring’
3 days ago
China’s biotech rise has been a persistent concern for federal health leaders...